APOLLO HOSPITALS ENTER. L vs POLY MEDICURE LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and POLY MEDICURE LIMITED (POLYMED) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L and POLY MEDICURE LIMITED are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
52.88
13.42
P/B ratio
5.66
0.11%
Dividend yield
0.21%
₹135.04
EPS
₹31.78

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
11.20%
18.00%
Return on capital
14.00%
15.00%
EBITDA margin
24.00%
7.94%
Net margin
17.12%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
18.92%
33.39%
Profit CAGR (3Y)
21.49%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹17,033 Cr
₹25,228 Cr
Revenue
₹1,875 Cr
₹2,003 Cr
Net profit
₹321 Cr
0.90
Debt / equity
0.11
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
POLY MEDICURE LIMITED
  • + ["Company has delivered good profit growth of 19.4% CAGR over last 5 years"]
  • ["Debtor days have increased from 83.8 to 103 days.", "Working capital days have increased from 126 days to 249 days"]
APOLLO HOSPITALS ENTER. L full analysis POLY MEDICURE LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.